A RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, MULTICENTER SAFETY AND EFFICACY STUDY OF A SINGLE INTRAPROSTATIC TREATMENT OF PRX302 FOR LOWER URINARY TRACT SYMPTOMS SECONDARY TO BENIGN PROSTATE HYPERPLASIA (THE PLUS I TRIAL)

Registry ID

PRX302-3-01

Source registry

HEALTH_CANADA

Status

Pending

Study type

INTERVENTIONAL

Sponsor

SOPHIRIS BIO CORP.

Start date

2014-03-17

Last update

2014-03-20

Conditions

• PROSTATE HYPERPLASIA

View on source registry